Roche Holding AG (RHHVF)
289.09
-5.79
(-1.96%)
USD |
OTCM |
Nov 14, 16:00
Roche Total Assets (Quarterly): 106.56B for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 106.56B |
| June 30, 2024 | 106.56B |
| December 31, 2023 | 107.71B |
| June 30, 2023 | 93.82B |
| June 30, 2023 | 93.82B |
| December 31, 2022 | 95.08B |
| June 30, 2022 | 90.88B |
| June 30, 2022 | 90.88B |
| December 31, 2021 | 100.99B |
| June 30, 2021 | 95.43B |
| June 30, 2021 | 95.43B |
| December 31, 2020 | 98.59B |
| June 30, 2020 | 84.49B |
| June 30, 2020 | 84.49B |
| December 31, 2019 | 85.76B |
| June 30, 2019 | 82.09B |
| June 30, 2019 | 82.09B |
| December 31, 2018 | 79.75B |
| June 30, 2018 | 78.35B |
| June 30, 2018 | 78.35B |
| December 31, 2017 | 78.72B |
| June 30, 2017 | 75.19B |
| June 30, 2017 | 75.19B |
| December 31, 2016 | 75.49B |
| June 30, 2016 | 76.06B |
| Date | Value |
|---|---|
| June 30, 2016 | 76.06B |
| December 31, 2015 | 76.65B |
| June 30, 2015 | 74.38B |
| June 30, 2015 | 74.38B |
| December 31, 2014 | 76.39B |
| June 30, 2014 | 69.53B |
| June 30, 2014 | 69.53B |
| December 31, 2013 | 70.05B |
| June 30, 2013 | 62.86B |
| June 30, 2013 | 62.86B |
| December 31, 2012 | 70.99B |
| June 30, 2012 | 61.75B |
| June 30, 2012 | 61.75B |
| December 31, 2011 | 65.47B |
| June 30, 2011 | 66.36B |
| June 30, 2011 | 66.36B |
| December 31, 2010 | 65.28B |
| June 30, 2010 | 59.23B |
| December 31, 2009 | 72.00B |
| June 30, 2009 | 70.56B |
| December 31, 2008 | 71.20B |
| June 30, 2008 | 69.21B |
| June 30, 2008 | 69.21B |
| December 31, 2007 | 69.15B |
| June 30, 2007 | 62.71B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
84.49B
Minimum
Jun 2020
107.71B
Maximum
Dec 2023
95.37B
Average
95.08B
Median
Dec 2022
Total Assets (Quarterly) Benchmarks
| AC Immune SA | 290.33M |
| CRISPR Therapeutics AG | 2.256B |
| Addex Therapeutics Ltd | 15.24M |
| NLS Pharmaceutics Ltd | 1.194M |
| Molecular Partners AG | 183.31M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 69.98B |
| Shareholders Equity (Quarterly) | 32.20B |
| Debt to Equity Ratio | 1.19 |
| Current Ratio | 1.264 |
| Net Debt Paydown Yield | -1.66% |